Ignite Creation Date:
2024-07-17 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06499285
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-07-05
Brief Title:
The Efficacy and Safety of Elritercept in Adult Participants With Very Low Low or Intermediate Risk Myelodysplastic Syndromes MDS With Anemia RENEW
Sponsor:
Keros Therapeutics Inc
Organization:
Keros Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-12-31
Start Date Type:
ESTIMATED
Primary Completion Date:
2032-03-14
Primary Completion Date Type:
ESTIMATED
Completion Date:
2032-03-14
Completion Date Type:
ESTIMATED
First Submit Date:
2024-07-05
First Submit QC Date:
None
Study First Post Date:
2024-07-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-11
Last Update Post Date:
2024-07-12
Last Update Post Date Type:
ACTUAL